Consolidation Therapy

What is consolidation therapy ... Instead of understanding this term with regard to therapy, understand it with regard to timing: consolidation therapy is a therapy administered to a cancer patient immediately after induction therapy (this just means the first therapy received), for the purposes of 'mopping up' any remaining, wayward, hard-to-find cancer cells lurking in the body.

If a person goes in for breast cancer surgery (induction therapy), they might receive radiation afterwards (consolidation therapy).

Follicular lymphoma patients sometimes undergo combination chemotherapy (induction) followed by rituximab (consolidation).

A third step, maintenance therapy, is sometimes involved in treatment plans. However, not all treatment approaches are the same and they will differ depending on cancer type, among other factors.

Consolidation Therapy: Game-Changer in Pediatric Cancers

Perhaps the most complete example of consolidation therapy comes from pediatric cancers.

Children with acute lymphoblastic leukemia (ALL), the most commonly diagnosed pediatric cancer, first undergo an induction phase, consisting of two to four chemotherapy drugs and perhaps a steroid. This phase is designed to put the leukemia into remission by killing over 99 percent of the cancer cells in the child's body.

Back in the 1970s, kids with ALL received the induction phase, which lasts about one month, then they entered the maintenance phase, which lasts as long as two years. But kids kept relapsing. They were relapsing because induction therapy was putting them into what their tests told them was complete remission, when in fact cancer cells remained. When testing for the leukemia cells became more sensitive, it became clear that induction therapy wasn't achieving complete remissions.

Consolidation therapy was added to the protocol, and now kids with ALL have an excellent chance of achieving full and lasting remission.

Consolidation Therapy: By Other Names

As is very typical in cancer terminology, consolidation therapy is sometimes referred to using other terms, including:

  • Adjuvant therapy
  • Intensification therapy
  • Postremission therapy

They mean the same thing; the central idea behind it remains the same. As MedicineNet puts it, consolidation therapy "consolidates the gains obtained [from induction therapy, to] further reduce the number of cancer cells and enhance the likelihood of a durable complete remission."

It's important to remember that induction therapy can mean many things—surgery, chemotherapy, radiation, even a stem cell transplant, or even chemotherapy AND a transplant—and that consolidation can too—immunotherapy, chemotherapy, radiation, antibody drug conjugates and more. So there's no one single treatment that means 'consolidation', it is simply going to be a therapy that follows closely behind a prior therapy and is meant to chase remaining cancer cells in the body.

You can see the term at work in this video of Dr. Paul Richardson discussing consolidation for multiple myeloma.

Sources: NCI, ACS

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap